Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma.
Versluis JM, Reijers ILM, Rozeman EA, Menzies AM, van Akkooi ACJ, Wouters MW, Ch'ng S, Saw RPM, Scolyer RA, van de Wiel BA, Schilling B, Long GV, Blank CU.
Versluis JM, et al. Among authors: wouters mw.
Eur J Cancer. 2021 May;148:51-57. doi: 10.1016/j.ejca.2021.02.012. Epub 2021 Mar 15.
Eur J Cancer. 2021.
PMID: 33735809
Clinical Trial.